Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2013 (2013), Article ID 294312, 9 pages
http://dx.doi.org/10.1155/2013/294312
Clinical Study

Effect of Folic Acid Supplementation in Pregnancy on Preeclampsia: The Folic Acid Clinical Trial Study

1OMNI Research Group, Department of Obstetrics and Gynecology, Faculty of Medicine, Ottawa Hospital, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6
2Clinical Epidemiology Program, Ottawa Hospital Research Institute, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6
3Department of Epidemiology, Biostatistics and Occupational Health and Department of Pediatrics, McGill University Faculty of Medicine, 3175 Cote Ste. Catherine, Montreal, QC, Canada H3T 1C5
4Department of Epidemiology and Community Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, Canada
5Department of Obstetrics and Gynecology, Ste. Justine Hospital, 3175 Cote Ste. Catherine, Montreal, QC, Canada H3T 1C5
6Queen’s Perinatal Research Unit, Department of Obstetrics and Gynecology, Queen’s University, 76 Stuart Street, Connell 4, Kingston, ON, Canada K7L 2V7
7Department of Medicine, Faculty of Medicine, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada K1H 8L6

Received 26 March 2013; Accepted 8 July 2013

Academic Editor: Fabio Facchinetti

Copyright © 2013 Shi Wu Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “ACOG practice bulletion no. 33: diagnosis and management of preeclampsia and eclampsia,” Obstetrics & Gynecology, vol. 99, pp. 159–167, 2002.
  2. J. M. Roberts and K. Y. Lain, “Recent insights into the pathogenesis of pre-eclampsia,” Placenta, vol. 23, no. 5, pp. 359–372, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Duley, “Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean,” British Journal of Obstetrics and Gynaecology, vol. 99, no. 7, pp. 547–553, 1992. View at Google Scholar · View at Scopus
  4. B. M. Sibai, “Hypertension in pregnancy,” Obstetrics and Gynecology Clinics of North America, vol. 19, no. 4, pp. 615–632, 1992. View at Google Scholar · View at Scopus
  5. J. Zhang, S. Meikle, and A. Trumble, “Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States,” Hypertension in Pregnancy, vol. 22, no. 2, pp. 203–212, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. H. U. Irgens, L. Reisæter, L. M. Irgens, and R. T. Lie, “Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study,” British Medical Journal, vol. 323, no. 7323, pp. 1213–1216, 2001. View at Google Scholar · View at Scopus
  7. B. J. Wilson, M. S. Watson, G. J. Prescott et al., “Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study,” British Medical Journal, vol. 326, no. 7394, pp. 845–849, 2003. View at Google Scholar · View at Scopus
  8. P. J. Meis, R. L. Goldenberg, B. M. Mercer et al., “The preterm prediction study: risk factors for indicated preterm births,” American Journal of Obstetrics and Gynecology, vol. 178, no. 3, pp. 562–567, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. K. L. Ales, W. Frayer, G. Hawks, P. M. Auld, and M. L. Druzin, “Development and validation of a multivariate predictor of mortality in very low birth weight,” Journal of Clinical Epidemiology, vol. 41, no. 11, pp. 1095–1103, 1988. View at Google Scholar · View at Scopus
  10. M. F. Whitfield, R. V. E. Grunau, and L. Holsti, “Extremely premature (≤800 g) schoolchildren: multiple areas of hidden disability,” Archives of Disease in Childhood, vol. 77, no. 2, pp. F85–F90, 1997. View at Google Scholar · View at Scopus
  11. D. J. P. Barker, “Fetal programming and public health,” in Fetal Programming: Influences on Development and Disease in Later Life, P. M. S. O’Brien, T. Wheeler, and D. J. P. Barker, Eds., pp. 3–11, RCOG Press, London, UK, 1999. View at Google Scholar
  12. G. A. Dekker and B. M. Sibai, “Etiology and pathogenesis of preeclampsia: current concepts,” American Journal of Obstetrics and Gynecology, vol. 179, no. 5, pp. 1359–1375, 1998. View at Google Scholar · View at Scopus
  13. S. W. Wen, X. Chen, M. Rodger et al., “Folic acid supplementation in early second trimester and the risk of preeclampsia,” American Journal of Obstetrics and Gynecology, vol. 198, no. 1, pp. 45.e1–45.e7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. W. Wen, J. Zhou, Q. Yang, W. Fraser, O. Olatunbosun, and M. Walker, “Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes,” Canadian Medical Association Journal, vol. 179, no. 12, pp. 1263–1268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. M. Bodnar, G. Tang, R. B. Ness, G. Harger, and J. M. Roberts, “Periconceptional multivitamin use reduces the risk of preeclampsia,” American Journal of Epidemiology, vol. 164, no. 5, pp. 470–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hernández-Díaz, M. M. Werler, C. Louik, and A. A. Mitchell, “Risk of gestational hypertension in relation to folic acid supplementation during pregnancy,” American Journal of Epidemiology, vol. 156, no. 9, pp. 806–812, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Catov, E. A. Nohr, L. M. Bodnar, V. K. Knudson, S. F. Olsen, and J. Olsen, “Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort,” American Journal of Epidemiology, vol. 169, no. 11, pp. 1304–1311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Li, R. Ye, L. Zhang, H. Li, J. Liu, and A. Ren, “Folic acid supplementation during early pregnancy and the risk of gestational hypertension and preeclampsia,” Hypertension, vol. 61, no. 4, pp. 873–879, 2013. View at Google Scholar
  19. S. Timmermans, V. W. V. Jaddoe, L. M. Silva et al., “Folic acid is positively associated with uteroplacental vascular resistance: The Generation R Study,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 21, no. 1, pp. 54–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Herrmann, S. Isber, R. Obeid, M. Herrmann, and M. Jouma, “Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status,” Clinical Chemistry and Laboratory Medicine, vol. 43, no. 10, pp. 1139–1146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Bánhidy, A. Dakhlaoui, I. Dudás, and A. E. Czeizel, “Birth outcomes of newborns after folic Acid supplementation in pregnant women with early and late pre-eclampsia: a population-based study,” Advances in Preventive Medicine, vol. 2011, Article ID 127369, 7 pages, 2011. View at Publisher · View at Google Scholar
  22. D. H. M. Charles, A. R. Ness, D. Campbell, G. D. Smith, E. Whitley, and M. H. Hall, “Folic acid supplements in pregnancy and birth outcome: re-analysis of a large randomised controlled trial and update of Cochrane review,” Paediatric and Perinatal Epidemiology, vol. 19, no. 2, pp. 112–124, 2005. View at Google Scholar · View at Scopus
  23. A. T. Merchant, G. Msamanga, E. Villamor et al., “Multivitamin supplementation of HIV-positive women during pregnancy reduces hypertension,” Journal of Nutrition, vol. 135, no. 7, pp. 1776–1781, 2005. View at Google Scholar · View at Scopus
  24. E. Keating, P. Gonçalves, I. Campos, F. Costa, and F. Martel, “Folic acid uptake by the human syncytiotrophoblast: interference by pharmacotherapy, drugs of abuse and pathological conditions,” Reproductive Toxicology, vol. 28, no. 4, pp. 511–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. E. Czeizel and M. Tomcsik, “Acute toxicity of folic acid in pregnant women,” Teratology, vol. 60, pp. 3–4, 1999. View at Google Scholar
  26. K. H. Bønaa, I. Njølstad, P. M. Ueland et al., “Homocysteine lowering and cardiovascular events after acute myocardial infarction,” The New England Journal of Medicine, vol. 354, no. 15, pp. 1578–1588, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. B. F. Cole, J. A. Baron, R. S. Sandler et al., “Folic acid for the prevention of colorectal adenomas: a randomized clinical trial,” Journal of the American Medical Association, vol. 297, no. 21, pp. 2351–2359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Kim, “Folic acid supplementation and cancer risk: point,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2220–2225, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. N. Wien, E. Pike, T. Wisløff, A. Staff, S. Smeland, and M. Klemp, “Cancer risk with folic acid supplements: a systematic review and meta-analysis,” BMJ Open, vol. 2, no. 1, Article ID e000653, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Charles, A. R. Ness, D. Campbell, G. D. Smith, and M. H. Hall, “Taking folate in pregnancy and risk of maternal breast cancer,” British Medical Journal, vol. 329, no. 7479, pp. 1375–1376, 2004. View at Google Scholar · View at Scopus
  31. G. P. Oakley and J. S. Mandel, “Commentary: Folic acid fortification remains an urgent health priority,” British Medical Journal, vol. 329, no. 7479, p. 1376, 2004. View at Google Scholar · View at Scopus
  32. S. C. Larsson, E. Giovannucci, and A. Wolk, “Folate and risk of breast cancer: a meta-analysis,” Journal of the National Cancer Institute, vol. 99, no. 1, pp. 64–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Ebbing, K. H. Bønaa, O. Nygård et al., “Cancer incidence and mortality after treatment with folic acid and vitamin B12,” Journal of the American Medical Association, vol. 302, no. 19, pp. 2119–2126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Armitage, L. Bowman, R. J. Clarke et al., “Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial,” Journal of the American Medical Association, vol. 303, no. 24, pp. 2486–2494, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. Baggott, R. A. Oster, and T. Tamura, “Meta-analysis of cancer risk in folic acid supplementation trials,” Cancer Epidemiology, vol. 36, no. 1, pp. 78–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Clarke, J. Halsey, S. Lewington et al., “Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals,” Archives of Internal Medicine, vol. 170, no. 18, pp. 1622–1631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. Health Canada, Nutrition for a Healthy Pregnancy: Guideline for the Childbearing Years, Minister of Public Works and Government Services Canada, Ottawa, Canada, 1999.
  38. R. D. Wilson, J. Johnson, P. Wyatt et al., “Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies,” Journal of Obstetrics and Gynaecology Canada, vol. 29, no. 12, pp. 1003–1026, 2007. View at Google Scholar · View at Scopus
  39. K. Duckitt and D. Harrington, “Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies,” British Medical Journal, vol. 330, no. 7491, pp. 565–567, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Lemeshow, D. W. Hosmer Jr., J. Klar, and J. K. Lwanga, Adequacy of Sample Size in Health Studies, World Health Organization, Geneva, Switzerland, 1990.
  41. K. M. Laurence, C. O. Carter, and P. A. David, “Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects,” British Journal of Preventive & Social Medicine, vol. 22, no. 4, pp. 212–222, 1968. View at Google Scholar · View at Scopus
  42. R. G. Record and T. McKeown, “Congenital malformations of the central nervous system. I. Survey of 930 cases,” British Journal of Preventive and Social Medicine, vol. 3, pp. 183–219, 1949. View at Google Scholar
  43. R. W. Smithells, S. Sheppard, and C. J. Schorah, “Vitamin deficiencies and neural tube defects,” Archives of Disease in Childhood, vol. 51, no. 12, pp. 944–950, 1976. View at Google Scholar · View at Scopus
  44. E. Hibbard and R. W. Smithells, “Folic acid metabolism and human embryopathy,” The Lancet, vol. 285, no. 7398, p. 1254, 1965. View at Google Scholar · View at Scopus
  45. J. B. Thiersch, “Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route,” American journal of obstetrics and gynecology, vol. 63, no. 6, pp. 1298–1304, 1952. View at Google Scholar · View at Scopus
  46. N. Wald, J. Sneddon, J. Densem, C. Frost, and R. Stone, “Prevention of neural tube defects: results of the Medical Research Council vitamin study,” The Lancet, vol. 338, no. 8760, pp. 131–137, 1991. View at Publisher · View at Google Scholar · View at Scopus
  47. A. E. Czeizel and I. Dudas, “Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation,” The New England Journal of Medicine, vol. 327, no. 26, pp. 1832–1835, 1992. View at Google Scholar · View at Scopus
  48. J. Fletcher, A. Gurr, F. R. Fellingham, T. A. J. Prankerd, H. A. Brant, and D. N. Menzies, “The value of folic acid supplements in pregnancy,” Journal of Obstetrics and Gynaecology of the British Commonwealth, vol. 78, no. 9, pp. 781–785, 1971. View at Google Scholar · View at Scopus
  49. A. F. Fleming, J. P. Hendrickse, and N. C. Allan, “The prevention of megaloblastic anaemia in pregnancy in Nigeria,” The Journal of obstetrics and gynaecology of the British Commonwealth, vol. 75, no. 4, pp. 425–432, 1968. View at Google Scholar · View at Scopus
  50. K. M. Laurence, N. James, and M. H. Miller, “Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects,” British Medical Journal, vol. 282, no. 6275, pp. 1509–1511, 1981. View at Google Scholar · View at Scopus
  51. A. R. Bernasconi, A. Liste, N. Del Pino, G. J. Rosa Diez, and R. M. Heguilén, “Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure,” Nephrology, vol. 11, no. 2, pp. 137–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. C. Z. Chuang, A. Boyles, B. Legardeur, J. Su, S. Japa, and A. Lopez-S, “Effects of riboflavin and folic acid supplementation on plasma homocysteine levels in healthy subjects,” The American journal of the medical sciences, vol. 331, no. 2, pp. 65–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Guven, A. Coskun, I. E. Ertas, M. Aral, B. Zencirci, and H. Oksuz, “Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and vitamin b12 levels with the severity of preeclampsia and fetal birth weight,” Hypertension in Pregnancy, vol. 28, no. 2, pp. 190–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Lindblad, S. Zaman, A. Malik et al., “Folate, vitamin B12, and homocysteine levels in South Asian women with growth-retarded fetuses,” Acta Obstetricia et Gynecologica Scandinavica, vol. 84, no. 11, pp. 1055–1061, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. R. W. Powers, R. W. Evans, A. K. Majors et al., “Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation,” American Journal of Obstetrics and Gynecology, vol. 179, no. 6 I, pp. 1605–1611, 1998. View at Publisher · View at Google Scholar · View at Scopus
  56. C. Antoniades, C. Shirodaria, N. Warrick et al., “5-Methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling,” Circulation, vol. 114, no. 11, pp. 1193–1201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. K. S. Brown, Y. Huang, Z. Lu, W. Jian, I. A. Blair, and A. S. Whitehead, “Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells,” Atherosclerosis, vol. 189, no. 1, pp. 133–141, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. K. E. MacKenzie, E. J. Wiltshire, R. Gent, C. Hirte, L. Piotto, and J. J. Couper, “Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus,” Pediatrics, vol. 118, no. 1, pp. 242–253, 2006. View at Publisher · View at Google Scholar · View at Scopus